Literature DB >> 2255386

Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice.

S J Czuczwar1, U Małek, Z Kleinrok.   

Abstract

Among three calcium channel inhibitors studied, nifedipine (20 mg/kg) moderately inhibited pentylenetetrazol (115 mg/kg, s.c.)-induced convulsions, whilst diltiazem (up to 20 mg/kg) and verapamil (up to 20 mg/kg) were without effect. The combinations of nifedipine (10 and 20 mg/kg) with valproate (100 mg/kg) or phenobarbital (6.25 mg/kg) resulted in significant protection against pentylenetetrazol-induced seizures. Combined treatment of nifedipine (5-20 mg/kg) with ethosuximide (100 mg/kg) also provided a clearcut anticonvulsant action. The antiepileptic drugs alone, in the above doses, were ineffective. The combination of diltiazem (10-20 mg/kg) and ethosuximide (100 mg/kg) produced protection against pentylenetetrazol, comparable to that of ethosuximide (200 mg/kg) alone. No pharmacokinetic interactions were found in the case of ethosuximide, whilst nifedipine (10 mg/kg) increased the levels of phenobarbital and valproate in plasma. The combination of diltiazem with the remaining antiepileptics were ineffective. Verapamil (up to 20 mg/kg) was without effect upon the action of the antiepileptic drugs tested. Finally, none of the calcium channel inhibitors studied influenced the action of diazepam (0.2 mg/kg). It may be concluded that combinations of ethosuximide, with either nifedipine or diltiazem, may be promising for the treatment of absence epilepsy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255386     DOI: 10.1016/0028-3908(90)90145-h

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery.

Authors:  Deependra Kumar; Nina Dedic; Cornelia Flachskamm; Stephanie Voulé; Jan M Deussing; Mayumi Kimura
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

3.  Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice.

Authors:  M Gasior; R Kamiński; T Brudniak; Z Kleinrok; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Potentiating effects of L-type Ca(2+) channel blockers on pentobarbital-induced hypnosis are influenced by serotonergic system.

Authors:  X Zhao; X-Y Cui; Q-P Chu; B-Q Chen; X-M Wang; Z-B Lin; X-J Li; B-S Ku; Y-H Zhang
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

5.  Effects of diltiazem in convulsive states differ from those previously reported for dihydropyridine calcium channel antagonists.

Authors:  W P Watson; H J Little
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

6.  Effects of subacutely administered saiboku-to, an oriental herbal medicine, on pharmacodynamics and pharmacokinetics of diazepam in rodents.

Authors:  M Yuzurihara; Y Ikarashi; K Ishihara; H Kushida; A Ishige; H Sasaki; Y Maruyama
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

7.  Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures.

Authors:  D D Damasceno; A J Ferreira; M C Doretto; A P Almeida
Journal:  Braz J Med Biol Res       Date:  2012-07-19       Impact factor: 2.590

8.  Anticonvulsant activity of methanolic and aqueous extracts of Melissa parviflora in experimentally induced Swiss albino mice.

Authors:  Jalal Uddin Bhat; Qudsia Nizami; Asia Asiaf; Shabir Ahmad Parray; Shiekh Tanveer Ahmad; Mohammad Aslam; Razia Khanam; Mohammad Mujeeb; Sadiq Umar; Ayesha Siddiqi
Journal:  EXCLI J       Date:  2012-01-20       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.